Skip to main content

Table 5 Haplotype analysis associated with chemosensitivity in SETD2 polymorphism

From: Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients

Haplotype

CR (n, %)

NR (n, %)

χ2

p

OR (95% CI)

AGC

188 (50.9%)

102 (56.6%)

2.871

0.090

0.803 (0.623–1.035)

GAC

127 (34.3%)

62 (34.5%)

0.000

0.998

1.000 (0.767–1.303)

GGT

51 (13.9%)

16 (8.4%)

6.679

0.010

1.738 (1.138–2.652)